Characterization of bispecific antibodies that drive synthetic agonistic receptor - transduced T cells to mediate specific and conditional therapy in human pancreatic cancer models.
Eur. J. Cancer110, S3-S3 (2019)
Open Access Green as soon as Postprint is submitted to ZB.